NewsDesk @bactiman63 The Nigeria Centre for Disease Control and Prevention (NCDC) reported six additional confirmed Lassa fever cases during the week ending September 3, bringing the total confirmed cases...

NewsDesk @bactiman63 In a follow-upon the Lassa fever outbreak in Nigeria in 2023, the Nigeria Centre for Disease Control and Prevention (NCDC) reported 1378 suspected and 361 confirmed Lassa fever cases...

NewsDesk  @infectiousdiseasenews The Nigeria Centre for Disease Control (NCDC) reported 48 confirmed Lassa fever cases in the first week of 2022. This is up from 28 cases reported the last week of 2021. Two...

By NewsDesk  @bactiman63 The Nigeria Centre for Disease Control (NCDC) reported an additional confirmed Lassa fever cases the week ending February 21, bringing the country total to 102. In addition,...

By NewsDesk  @infectiousdiseasenews The Nigeria Centre for Disease Control (NCDC) reported 10 additional confirmed Lassa fever cases the week ending April 12, bringing the country total to 973 since...

By NewsDesk  @infectiousdiseasenews Officials with the Nigeria Centre for Disease Control (NCDC) report intensifying efforts as increasing number of Lassa fever cases are reported across states in the...

By NewsDesk  @infectiousdiseasenews The Lassa fever case count and death toll continues to rise in Nigeria this January. The Nigerian CDC reported an additional 81 confirmed Lassa cases during the week...

By NewsDesk  @infectiousdiseasenews Nigerian health officials reported five additional confirmed Lassa fever cases in the week ending Oct. 13. The cases were reported from Edo(2), Ondo(2) and Bauchi(1)...

By NewsDesk  @bactiman63 Lassa Fever Candidate Vaccine  Inovio Pharmaceuticals, Inc. announced Tuesday announced it has dosed subjects in a Phase 1, first-in-human clinical trial to evaluate INO-4500,...

Nigerian health officials reported an addition 16 Lassa fever cases during the most recent week, including two fatalities. The new confirmed cases were reported from five states – Edo(6), Ondo(4),...